LOS ANGELES CAPITAL MANAGEMENT LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 246 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$486,459
-78.7%
50,515
-76.5%
0.00%
-77.8%
Q2 2023$2,283,993
+12.8%
214,661
+11.5%
0.01%0.0%
Q1 2023$2,025,689
-18.8%
192,556
-4.4%
0.01%
-25.0%
Q4 2022$2,494,665
+57.1%
201,345
+31.3%
0.01%
+50.0%
Q3 2022$1,588,000
+131.5%
153,308
+157.8%
0.01%
+166.7%
Q2 2022$686,000
-8.3%
59,4730.0%0.00%0.0%
Q1 2022$748,000
+7.9%
59,4730.0%0.00%0.0%
Q4 2021$693,000
-11.8%
59,473
-1.1%
0.00%
-25.0%
Q3 2021$786,000
+5.6%
60,147
+4.1%
0.00%
+33.3%
Q2 2021$744,000
+9.1%
57,787
-5.3%
0.00%0.0%
Q1 2021$682,000
-57.9%
61,042
-57.1%
0.00%
-57.1%
Q4 2020$1,621,000
+25.9%
142,342
-0.6%
0.01%
+16.7%
Q3 2020$1,288,000
-20.6%
143,240
-8.9%
0.01%
-25.0%
Q2 2020$1,623,000
+6.0%
157,258
+3.6%
0.01%
-20.0%
Q1 2020$1,531,000
-6.2%
151,776
+23.7%
0.01%
+25.0%
Q4 2019$1,633,000
+146.7%
122,681
+59.1%
0.01%
+100.0%
Q3 2019$662,000
-21.5%
77,0970.0%0.00%
-20.0%
Q2 2019$843,000
+18.1%
77,097
+46.1%
0.01%
+25.0%
Q1 2019$714,000
+128.8%
52,752
+223.3%
0.00%
+100.0%
Q2 2018$312,000
-52.0%
16,315
-61.3%
0.00%
-50.0%
Q1 2018$650,00042,1200.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,855,515$43,661,00013.90%
BLUE JAY CAPITAL MANAGEMENT, LLC 772,369$11,810,0007.13%
Rubric Capital Management LP 1,275,000$19,495,0006.70%
SECTOR GAMMA AS 1,972,678$30,162,0005.68%
BRIDGER MANAGEMENT, LLC 1,879,313$28,735,0002.00%
Asymmetry Capital Management, L.P. 57,363$877,0001.63%
Orbimed Advisors 7,241,300$110,719,0001.41%
Broderick Brian C 144,476$2,209,0000.96%
Granahan Investment Management 1,408,000$21,528,0000.74%
Spark Investment Management LLC 499,200$7,632,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders